Geno Pharmaceuticals Private Limited Ramipril Export Data — India (DGFT 2022–2026)

Name: Geno Pharmaceuticals Private Limited Ramipril Export Records India — #2 Exporter, 686 Shipments, $14.0M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Ramipril

India Pharmaceutical Trade Intelligence

$89.8M177 Suppliers93 CountriesHS 30049071

ExportsIndia → UNITED KINGDOM35.0%India → FRANCE23.2%

ImportsMALTA → India$520.7K GERMANY → India$469.4K

#1 Supplier: MYLAN LABORATORIES #1 Buyer: CSP VIATRIS

Geno Pharmaceuticals Private Limited — Ramipril Exporter #2 | $14.0M Trade Value | TransData Nexus | TransData Nexus

Geno Pharmaceuticals Private Limited — Ramipril Exporter Profile

Indian Pharmaceutical Exporter · #2 for Ramipril · $14.0M export value · DGFT Verified

Geno Pharmaceuticals Private Limited is the #2 Indian exporter of Ramipril with $14.0M in export value and 686 verified shipments. Geno Pharmaceuticals Private Limited holds a 15.6% market share in Ramipril exports across 1 countries. The company exports 2 pharmaceutical products worth $14.1M across 1 therapeutic categories.

Geno Pharmaceuticals Private Limited — Ramipril Export Profile: Buyers & Destinations

Geno Pharmaceuticals Private Limited Ramipril export treemap — buyers and destination countries | TransData Nexus

Where Does India Export Ramipril?

Country	Value	Shipments	Share
UNITED KINGDOM	$31.4M	1,302	36.4%
FRANCE	$20.8M	549	24.1%
UNITED STATES	$12.9M	611	14.9%
CANADA	$5.6M	514	6.4%

Who Are the Top Buyers of Ramipril from India?

Buyer	Country	Value	Orders
WOCKHARDT UK LIMITED	UNITED KINGDOM	$6.7M	276
CRESCENT PHARMA LTD	UNITED KINGDOM	$5.8M	191
BROWN AND BURK UK LIMITED	UNITED KINGDOM	$4.0M	125
ZENTIVA ITALIA SRL	ITALY	$3.8M	169
M/S CRESCENT PHARMA LTD.	UNITED KINGDOM	$3.1M	208
MILPHARM LIMITED,	UNITED KINGDOM	$2.6M	52
CSP VIATRIS SANTE AT CSP- LAB,	FRANCE	$2.2M	44
APOTEX INC,	CANADA	$1.8M	45
SANOFI SAGLIK URUNLERI LTD STI	TURKEY	$1.1M	22
CSP VIATRIS SANT? AT CSP- LAB	FRANCE	$1.0M	20

India's Ramipril is purchased by 389 buyers worldwide. The top buyer is WOCKHARDT UK LIMITED (UNITED KINGDOM), followed by CRESCENT PHARMA LTD and BROWN AND BURK UK LIMITED.

How Does Geno Pharmaceuticals Private Limited Compare to Nearest Ramipril Exporters?

Exporters ranked immediately above and below #2 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	MYLAN LABORATORIES LIMITED	$16.0M	320	5	$50.0K
2	GENO PHARMACEUTICALS PRIVATE LIMITED ★	$14.0M	686	1	$20.5K
3	AUROBINDO PHARMA LTD	$13.3M	811	8	$16.4K
5	IND SWIFT LIMITED	$6.4M	307	3	$20.8K

Geno Pharmaceuticals Private Limited ranks #2 among 177 Indian Ramipril exporters. Average shipment value of $20.5K compared to the market average of $466.2K. The closest competitors by value are MYLAN LABORATORIES LIMITED and AUROBINDO PHARMA LTD.

Which Indian Ports Ship Ramipril Exports?

Port	Shipments	% Share
NHAVA SHEVA SEA (INNSA1)	658	13.2%
JNPT/ NHAVA SHEVA SEA	553	11.1%
SAHAR AIR CARGO ACC (INBOM4)	305	6.1%
SAHAR AIR	291	5.8%
JNPT	271	5.4%
DELHI AIR CARGO ACC (INDEL4)	214	4.3%
DELHI AIR	201	4.0%
VIZAG SEA	194	3.9%

Geopolitical & Trade Policy Impact on Geno Pharmaceuticals Private Limited's Ramipril Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Geno Pharmaceuticals. The Israel-Iran conflict has disrupted key shipping routes in the Red Sea, leading to increased freight costs and extended transit times (pharmaceuticalcommerce.com). For a company exporting time-sensitive cardiovascular drugs, these disruptions can impact delivery schedules and inventory management.

Conversely, the United States' imposition of tariffs on Indian pharmaceutical imports in 2025 has prompted Indian exporters to reassess their market strategies (itisbl.com). While these tariffs primarily targeted branded or patented pharmaceuticals, the broader trade tensions have led to a cautious approach among exporters. However, India's strength in generic medicines, which constitute a significant portion of its exports to the U.S., may mitigate some of these impacts.

The recent India–European Union Free Trade Agreement, signed in January 2026, offers a silver lining (en.wikipedia.org). The agreement eliminates tariffs on pharmaceuticals, potentially enhancing market access for Indian exporters. For Geno Pharmaceuticals, this could translate into increased competitiveness and expanded opportunities within the EU market.

Geno Pharmaceuticals Private Limited — Regulatory Compliance & Quality Standards

India's pharmaceutical industry has made significant strides in regulatory compliance. As of 2024, the country boasts 752 FDA-approved, 2,050 WHO GMP-certified, and 286 EDQM-approved manufacturing facilities (business-standard.com). This robust compliance framework enhances the credibility of Indian exporters.

For Geno Pharmaceuticals, adherence to these stringent quality standards is crucial, especially given its focus on cardiovascular drugs, where patient safety is paramount. Maintaining compliance not only ensures market access but also builds trust with international partners and regulatory bodies.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Ramipril shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Geno Pharmaceuticals Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 93+ countries, 389+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Ramipril

Ramipril

Geno Pharmaceuticals Private Limited — Ramipril Exporter Profile

Geno Pharmaceuticals Private Limited — Ramipril Export Profile: Buyers & Destinations

Where Does India Export Ramipril?

Who Are the Top Buyers of Ramipril from India?

What Is India's Total Ramipril Export Value and How Much Does Geno Pharmaceuticals Private Limited Contribute?

What Is the Average Shipment Value for Geno Pharmaceuticals Private Limited's Ramipril Exports?

How Does Geno Pharmaceuticals Private Limited Compare to Other Indian Ramipril Exporters?

Regulatory Requirements: Exporting Ramipril to Key Markets

United Kingdom — MHRA

United States — FDA

How Does Geno Pharmaceuticals Private Limited Compare to Nearest Ramipril Exporters?

Which Indian Ports Ship Ramipril Exports?

What Other Cardiovascular Products Does Geno Pharmaceuticals Private Limited Export?

Geopolitical & Trade Policy Impact on Geno Pharmaceuticals Private Limited's Ramipril Exports

Geno Pharmaceuticals Private Limited — Regulatory Compliance & Quality Standards

About Geno Pharmaceuticals Private Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Ramipril Export Data from Geno Pharmaceuticals Private Limited

Ramipril Stats

Company Overview

Top Products by Geno Pharmaceuticals Private Limited

Related Analysis

Need Detailed Export Data?

Data Source